Formidable Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.12M | Buy |
9,748
+117
| +1% | +$25.2K | 0.34% | 56 |
|
|
2026
Q1 | $2.2M | Sell |
9,631
-592
| -6% | -$131K | 0.34% | 55 |
|
|
2025
Q4 | $2.37M | Sell |
10,223
-171
| -2% | -$39K | 0.34% | 48 |
|
|
2025
Q3 | $1.93M | Sell |
10,394
-196
| -2% | -$39.9K | 0.3% | 65 |
|
|
2025
Q2 | $2.22M | Hold |
10,590
| – | – | 0.37% | 52 |
|
|
2025
Q1 | $2.22M | Buy |
10,590
+119
| +1% | +$23.1K | 0.37% | 52 |
|
|
2024
Q4 | $1.86M | Sell |
10,471
-440
| -4% | -$80.9K | 0.31% | 67 |
|
|
2024
Q3 | $2.15M | Sell |
10,911
-176
| -2% | -$32.8K | 0.34% | 57 |
|
|
2024
Q2 | $1.9M | Buy |
11,087
+275
| +3% | +$45.6K | 0.31% | 63 |
|
|
2024
Q1 | $1.97M | Buy |
10,812
+5,290
| +96% | +$912K | 0.32% | 62 |
|
|
2023
Q4 | $856K | Sell |
5,522
-43
| -0.8% | -$6.27K | 0.18% | 109 |
|
|
2023
Q3 | $830K | Buy |
5,565
+31
| +0.6% | +$4.55K | 0.18% | 102 |
|
|
2023
Q2 | $746K | Sell |
5,534
-480
| -8% | -$70.4K | 0.16% | 128 |
|
|
2023
Q1 | $964K | Buy |
6,014
+301
| +5% | +$46K | 0.2% | 91 |
|
|
2022
Q4 | $923K | Sell |
5,713
-252
| -4% | -$38.6K | 0.21% | 92 |
|
|
2022
Q3 | $897K | Sell |
5,965
-105
| -2% | -$15.1K | 0.21% | 92 |
|
|
2022
Q2 | $921K | Sell |
6,070
-25
| -0.4% | -$3.82K | 0.21% | 90 |
|
|
2022
Q1 | $988K | Sell |
6,095
-7,771
| -56% | -$1.13M | 0.19% | 100 |
|
|
2021
Q4 | $1.88M | Sell |
13,866
-1,875
| -12% | -$221K | 0.36% | 51 |
|
|
2021
Q3 | $1.7M | Buy |
15,741
+6,259
| +66% | +$715K | 0.32% | 59 |
|
|
2021
Q2 | $1.1M | Buy |
9,482
+633
| +7% | +$71.3K | 0.24% | 84 |
|
|
2021
Q1 | $955K | Buy |
8,849
+947
| +12% | +$101K | 0.21% | 109 |
|
|
2020
Q4 | $838K | Buy |
7,902
+2,155
| +37% | +$207K | 0.19% | 104 |
|
|
2020
Q3 | $496K | Buy |
5,747
+164
| +3% | +$15.4K | 0.14% | 130 |
|
|
2020
Q2 | $559K | Buy |
5,583
+263
| +5% | +$23.2K | 0.16% | 123 |
|
|
2020
Q1 | $404K | Buy |
5,320
+198
| +4% | +$16.9K | 0.16% | 118 |
|
|
2019
Q4 | $451K | Buy |
+5,122
| New | +$425K | 0.14% | 129 |
|
|
2019
Q3 | – | Sell |
-4,527
| Closed | -$303K | – | 126 |
|
|
2019
Q2 | $303K | Sell |
4,527
-25,473
| -85% | -$2M | 0.1% | 155 |
|
|
2019
Q1 | $1K | Buy |
+30,000
| New | +$2.45M | ﹤0.01% | 187 |
|
|
2018
Q1 | – | Sell |
-4
| Closed | -$1K | – | 97 |
|
|
2017
Q4 | $1K | Sell |
4
-3,687
| -100% | -$347K | ﹤0.01% | 105 |
|
|
2017
Q3 | $328K | Sell |
3,691
-235
| -6% | -$17.9K | 0.14% | 143 |
|
|
2017
Q2 | $285K | Buy |
3,926
+10
| +0.3% | +$672 | 0.14% | 124 |
|
|
2017
Q1 | $259K | Sell |
3,916
-196
| -5% | -$12.3K | 0.11% | 156 |
|
|
2016
Q4 | $257K | Sell |
4,112
-134
| -3% | -$8.18K | 0.13% | 143 |
|
|
2016
Q3 | $268K | Sell |
4,246
-197
| -4% | -$12.8K | 0.13% | 139 |
|
|
2016
Q2 | $282K | Sell |
4,443
-1,107
| -20% | -$67.5K | 0.16% | 128 |
|
|
2016
Q1 | $338K | Hold |
5,550
| – | – | 0.24% | 93 |
|
|
2015
Q4 | $318K | Sell |
5,550
-6,350
| -53% | -$366K | 0.22% | 101 |
|
|
2015
Q3 | $647K | Sell |
11,900
-215
| -2% | -$14K | 0.43% | 51 |
|
|
2015
Q2 | $814K | Sell |
12,115
-50
| -0.4% | -$3.26K | 0.52% | 43 |
|
|
2015
Q1 | $788K | Sell |
12,165
-1,483
| -11% | -$89.6K | 0.52% | 42 |
|
|
2014
Q4 | $893K | Sell |
13,648
-17
| -0.1% | -$1.07K | 0.61% | 35 |
|
|
2014
Q3 | $864K | Sell |
13,665
-145
| -1% | -$8.05K | 0.57% | 38 |
|
|
2014
Q2 | $779K | Hold |
13,810
| – | – | 0.47% | 48 |
|
|
2014
Q1 | $703K | Buy |
13,810
+125
| +0.9% | +$6.32K | 0.49% | 45 |
|
|
2013
Q4 | $669K | Sell |
13,685
-25
| -0.2% | -$1.23K | 0.45% | 52 |
|
|
2013
Q3 | $630K | Buy |
+13,710
| New | +$608K | 0.54% | 50 |
|
Other funds holding ABBV
Formidable Asset Management's ABBV Position: Q2 2026 in Review
Formidable Asset Management increased its AbbVie (ABBV) stake by 1.2% in Q2 2026, buying an estimated $25.2K and bringing the position to 9,748 shares worth $2.12M. The position accounts for 0.34% of the portfolio, ranked #56.
Formidable Asset Management first reported a position in ABBV in Q3 2013 and has held it in 47 quarters since. The position peaked at $2.37M in Q4 2025. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Formidable Asset Management held 9,748 shares of AbbVie worth $2.12M as of Q2 2026.
- Formidable Asset Management bought 117 AbbVie shares in Q2 2026, an estimated $25.2K.
- AbbVie made up 0.34% of Formidable Asset Management's portfolio in Q2 2026, its #56 holding.
- Formidable Asset Management first reported a position in AbbVie in Q3 2013 and has held it in 47 quarters since.
- Formidable Asset Management's AbbVie position peaked at $2.37M in Q4 2025.
- 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.